HRAS and non-small cell lung carcinoma: The GSE3141 NSCLC samples were further stratified based on their molecular signature, corresponding to the expression levels of three of the main driver oncogenes in LC: MYCN, PI3K and HRAS (each divided in low and high expression sample groups).